Study of oral RXC008 for Crohn's disease strictures
Treatments studied
Part of Digestive system clinical trials.
This trial tests an oral medicine called RXC008 to see if it can help people with Crohn's disease who have narrowed areas in their small intestine (strictures). It aims to reduce symptoms and improve quality of life without needing surgery or dilation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old (BMI between 16 and 40).
- You have symptoms from a narrowed area in your small intestine caused by Crohn's disease.
- You have up to two narrowed areas, and the main one is reachable by a scope through the colon.
- Your Crohn's treatment has been stable for at least 12 weeks (for biologics) and you don't plan to change it during the study.
- You have not had balloon dilation or intestinal surgery in the past 6 months, and you're not expected to need it within the next 6 months.
- You do not have active fistulas, abscesses, or other serious complications of Crohn's disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at inflammation just before a narrowed section of the bowel in people with Crohn’s disease, using planned endoscopic balloon dilation. It may help doctors better understand what drives narrowing and inflammation so treatment can be timed and chosen more effectively.
This trial compares two ways to treat narrowed areas (strictures) in the gut caused by Crohn's disease: endoscopic strictureplasty versus balloon dilation. It aims to see which method works better for people whose strictures are manageable with a scope.
This trial tests a new approach that combines two procedures (stricturotomy and balloon dilation) against stricturotomy alone to treat short narrowed areas (strictures) caused by Crohn's disease. The goal is to see which method works better for keeping the bowel open longer.
This study compares medical treatment with surgery for people with Crohn's disease who have a narrowing (stricture) in their small intestine that causes blockages. The goal is to see which approach is better at managing symptoms and preventing complications.
This study tests a new oral treatment called EXL01 to see if it can prevent Crohn's disease from coming back after surgery to remove part of the small and large intestine. It may be an option if you are not planning to use strong immune-suppressing drugs (except anti-TNF) in the next 6 months.
This study looks at treatments for a new (de novo) narrow area in the bowel from Crohn’s disease. It aims to see which treatment works better at relieving blockage-type symptoms for the safest, most effective option.
Hear when a new Strictures Due to Crohn's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.